Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022.

Alexis Arzimanoglou; Milka Pringsheim; Gerhard Kluger; Pierre Genton; Carlos Perdomo; Manoj Malhotra

doi:10.1016/j.yebeh.2021.108275

Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022.

Alexis Arzimanoglou, Milka Pringsheim (Co-Autor/-in), Gerhard Kluger (Co-Autor/-in), Pierre Genton, Carlos Perdomo, Manoj Malhotra

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

4 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	108275
Fachzeitschrift	EPILEPSY & BEHAVIOR : E&B
Jahrgang	124
DOIs	https://doi.org/10.1016/j.yebeh.2021.108275
Publikationsstatus	Veröffentlicht - 2021

Zugriff auf Dokument

10.1016/j.yebeh.2021.108275

Dieses zitieren

@article{9ad4ad29d0084c48a0e1a3c308155ac6,

title = "Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022.",

keywords = "ADJUNCTIVE RUFINAMIDE, OPEN-LABEL, LONG-TERM, THERAPY, TRIAL",

author = "Alexis Arzimanoglou and Milka Pringsheim and Gerhard Kluger and Pierre Genton and Carlos Perdomo and Manoj Malhotra",

note = "Kluger; Pringsheim: Clinic for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and Adolescents, Krankenhausstr, Vogtareuth 20 83569, Germany; Research Institute for Rehabilitation, Transition and Palliation, PMU Salzburg, 5020 Salzburg, Austria",

year = "2021",

doi = "10.1016/j.yebeh.2021.108275",

language = "English",

volume = "124",

pages = "108275",

journal = "EPILEPSY & BEHAVIOR : E&B",

issn = "1525-5050",

publisher = "AAOS",

}

TY - JOUR

T1 - Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022.

AU - Arzimanoglou, Alexis

AU - Pringsheim, Milka

AU - Kluger, Gerhard

AU - Genton, Pierre

AU - Perdomo, Carlos

AU - Malhotra, Manoj

N1 - Kluger; Pringsheim: Clinic for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and Adolescents, Krankenhausstr, Vogtareuth 20 83569, Germany; Research Institute for Rehabilitation, Transition and Palliation, PMU Salzburg, 5020 Salzburg, Austria

PY - 2021

Y1 - 2021

KW - ADJUNCTIVE RUFINAMIDE

KW - OPEN-LABEL

KW - LONG-TERM

KW - THERAPY

KW - TRIAL

U2 - 10.1016/j.yebeh.2021.108275

DO - 10.1016/j.yebeh.2021.108275

M3 - Original Article

C2 - 34509883

SN - 1525-5050

VL - 124

SP - 108275

JO - EPILEPSY & BEHAVIOR : E&B

JF - EPILEPSY & BEHAVIOR : E&B

ER -